3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
HIV Infections
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cisplatin
63
Paclitaxel
56
Carboplatin
38
Taxes
24
Radiotherapy
21
Gemcitabine
16
Brachytherapy
15
Filgrastim
14
Doxorubicin
13
Topotecan
12
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
12
Docetaxel
11
Radiation
7
Granulocyte Colony-Stimulating Factor
7
Chemotherapy, Adjuvant
7
pegfilgrastim
6
Surgical Procedures, Operative
6
Radiotherapy, Intensity-Modulated
6
Polymerase Chain Reaction
6
Ifosfamide
6
Etoposide
6
Watchful Waiting
5
Radiotherapy, Conformal
5
Pemetrexed
5
Gene Expression Profiling
5
Fluorouracil
5
Celecoxib
5
Amifostine
5
Observation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Laser Therapy
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts